As usual, a second trial will be needed before UCB and Biogen can file dapirolizumab pegol with regulators. It will be called ...

FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.

This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.

Sapphire Foods India Ltd, Godawari Power & Ispat Ltd, Firstsource Solutions Ltd and National Aluminium Company Ltd are among the other gainers in the BSE's 'A' group today, 24 September 2024.

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

Insurance companies could be required to cover asthma inhalers at no cost in New York state. Assemblywoman Jessica ...

The companies now plan on starting this year another large study of their drug, dapirolizumab pegol, in the hopes that they can confirm its safety and effectiveness to drug regulators.

Johnson & Johnson's stock has seen modest gains in recent months. Read why I downgrade JNJ stock from buy to hold.

Biogen and Belgian partner UCB said on Tuesday their experimental lupus treatment met the main goal of a late-stage trial in ...

This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

The greatest disparity in BC-specific survival was observed in women with HR+ HER2− tumors, with Black women having a 50% ...

There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...